Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
europe top stories
life sciences
national blog main
national top stories
roche
billy dunn
biogen
biopharma
boston
boston blog main
boston top stories
clinical trials
deals
drug prices
drug pricing
duchenne
europe blog main
evrysdi
fda
gene therapy
genentech
ionis pharmaceuticals
licensing
m&a
muscular dystrophy
national
new york top stories
novartis
nusinersen
risdiplam
rna drugs
san francisco top stories
sarepta therapeutics
spinal muscular atrophy
spinraza
zolgensma
What
fda
medicine
roche
2
×
therapy
2
×
approval
approved
atrophy
betting
billion
biopharma
daily
deal
drug
duchenne
evrysdi
friday
gene
green
historic
home
intended
lights
liquid
muscular
new
oral
patients
puts
recently
risdiplam
rna
sarepta
second
spinal
swiss
therapeutics
won
Language
unset
Current search:
roche
×
therapy
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal